The invention relates to charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of using the same to reduce ocular toxicity associated with administration of antibody drug conjugates.
本发明涉及带电或前置带电的交联基团及细胞结合剂和药物的共轭物,其中包括带电或前置带电的交联基团,并使用相同的方法来减少与
抗体药物共轭物的给药相关的眼部毒性。